Image Rotator

Researchers to study the impact of adipose stem cell therapy on healing small and partial thickness rotator cuff tears.
Stem cell therapy trial at Sanford first of its kind in U.S. for shoulder injuries
Researchers to study the impact of adipose stem cell therapy on healing small and partial thickness rotator cuff tears.

There are currently no Featured Stories.


Sanford Research is a non-profit research organization that is a part of Sanford Health, the largest rural, not-for-profit health care system in the nation. Transformational gifts by Denny Sanford have propelled Sanford Research in its goal of becoming a world class research institution. Sanford Research has sought to establish a core of scientists that are studying disease at a fundamental level with the expectation that these current efforts will pay off in the future by advancing disease therapy and prevention.

 

With a team of over 200 researchers, Sanford Research is comprised of eight groups that bridge bench, translational and clinical research including: Cancer Biology and Immunotherapies, Pediatrics and Rare Diseases, Diabetes, Cellular Therapies and Stem Cell Biology, Enabling Technology, Environmental Influences on Health and Disease, Genetics and Genomics, and Population Health.

  • Oncology group chooses Sanford for first clinical trial

    Sanford launches national TAPUR Study for patients with advanced cancer. The clinical study offers FDA-approved, molecularly targeted drugs to participants.

    Learn More

  • Sanford launches innovative data project to improve patient care

    Dakota universities part of effort

    Learn More

  • New clinical trial launches at Sanford

    Head and neck cancer patients could benefit from new checkpoint inhibitor treatment at Sanford.

    Learn More

  • Sanford Enrolling Patients for Head, Neck Cancer Trial

    Studying investigational drug to determine if it helps activate immune system

    Learn More

Twitter Updates on Sanford Research
  • @MannyOhonme
    @SanfordHealth @drsanjaygupta @SanfordResearch @DrDavidPearce @Sanford_Palfy @SanfordShawnN @samanthabrez Congratul… https://t.co/KYTFwW3jHK

  • @DrDavidPearce
    RT @SanfordHealth: Watch #VitalSigns with @drsanjaygupta TODAY at 1:30 p.m. CDT to learn how Sanford Health is leading the way in stem cell…

  • @SanfordCoRDS
    RT @RareDiseases: RETWEET. The #raredisease community MUST ACT NOW & urge Senators to #VoteNO. https://t.co/gcp9zvJlD5

  • @KFS_Freedom
    RT @Rose_of_Sharon8: Hit 1200 +1500 at @KFS_Freedom today! RARE DISEASE patient impact! @TwitterMoments @GlobalGenes @SanfordCoRDS @RareAdv…

  • @DrDavidPearce
    RT @NIHDirector: Mismatch repair defects predict which #cancer patients will benefit from #immunotherapy drug. Learn more! #NIH https://t.c…

  • @Rose_of_Sharon8
    Hit 1200 +1500 at @KFS_Freedom today! RARE DISEASE patient impact! @TwitterMoments @GlobalGenes @SanfordCoRDS @RareAdvocates @RareDiseases